vs
Side-by-side financial comparison of Finwise Bancorp (FINW) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.
Finwise Bancorp is the larger business by last-quarter revenue ($42.7M vs $37.2M, roughly 1.1× Organogenesis Holdings Inc.). Over the past eight quarters, Finwise Bancorp's revenue compounded faster (47.0% CAGR vs -46.5%).
Finwise Bancorp is a U.S.-based financial holding company that operates primarily through its community banking subsidiary. It offers a full suite of retail and commercial financial services, including deposit accounts, personal loans, mortgage products, small business financing, and wealth management solutions, serving local retail consumers and small to medium-sized business clients across its regional operating markets.
Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.
FINW vs ORGO — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $42.7M | $37.2M |
| Net Profit | $2.7M | — |
| Gross Margin | — | 30.8% |
| Operating Margin | — | -185.1% |
| Net Margin | 6.4% | — |
| Revenue YoY | — | -57.1% |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.20 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $42.7M | $37.2M | ||
| Q4 25 | $46.9M | $225.6M | ||
| Q3 25 | $36.7M | $150.9M | ||
| Q2 25 | $25.1M | $101.0M | ||
| Q1 25 | $22.1M | $86.7M | ||
| Q4 24 | $21.1M | $126.7M | ||
| Q3 24 | $20.8M | $115.2M | ||
| Q2 24 | $19.8M | $130.2M |
| Q1 26 | $2.7M | — | ||
| Q4 25 | $3.9M | $43.7M | ||
| Q3 25 | $4.9M | $21.6M | ||
| Q2 25 | $4.1M | $-9.4M | ||
| Q1 25 | $3.2M | $-18.8M | ||
| Q4 24 | $2.8M | $7.7M | ||
| Q3 24 | $3.5M | $12.3M | ||
| Q2 24 | $3.2M | $-17.0M |
| Q1 26 | — | 30.8% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 72.6% | ||
| Q4 24 | — | 75.5% | ||
| Q3 24 | — | 76.7% | ||
| Q2 24 | — | 77.6% |
| Q1 26 | — | -185.1% | ||
| Q4 25 | 11.7% | 28.1% | ||
| Q3 25 | 17.5% | 13.7% | ||
| Q2 25 | 21.7% | -12.5% | ||
| Q1 25 | 20.1% | -30.9% | ||
| Q4 24 | 17.5% | 8.1% | ||
| Q3 24 | 22.2% | 5.4% | ||
| Q2 24 | 21.1% | -10.7% |
| Q1 26 | 6.4% | — | ||
| Q4 25 | 8.4% | 19.4% | ||
| Q3 25 | 13.3% | 14.3% | ||
| Q2 25 | 16.3% | -9.3% | ||
| Q1 25 | 14.4% | -21.7% | ||
| Q4 24 | 13.2% | 6.1% | ||
| Q3 24 | 16.6% | 10.7% | ||
| Q2 24 | 16.1% | -13.1% |
| Q1 26 | $0.20 | — | ||
| Q4 25 | $0.27 | $0.31 | ||
| Q3 25 | $0.34 | $0.11 | ||
| Q2 25 | $0.29 | $-0.10 | ||
| Q1 25 | $0.23 | $-0.17 | ||
| Q4 24 | $0.19 | $0.05 | ||
| Q3 24 | $0.25 | $0.09 | ||
| Q2 24 | $0.24 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $91.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $196.6M | — |
| Total Assets | $899.4M | $520.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $91.4M | ||
| Q4 25 | $163.4M | $93.7M | ||
| Q3 25 | $105.6M | $63.7M | ||
| Q2 25 | $90.1M | $73.1M | ||
| Q1 25 | $120.3M | $110.0M | ||
| Q4 24 | $109.2M | $135.6M | ||
| Q3 24 | $85.8M | $94.3M | ||
| Q2 24 | $89.0M | $89.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $62.3M | ||
| Q2 24 | — | $63.8M |
| Q1 26 | $196.6M | — | ||
| Q4 25 | $193.2M | $300.1M | ||
| Q3 25 | $187.8M | $255.1M | ||
| Q2 25 | $182.0M | $233.2M | ||
| Q1 25 | $177.4M | $242.9M | ||
| Q4 24 | $173.7M | $262.9M | ||
| Q3 24 | $170.4M | $278.5M | ||
| Q2 24 | $165.8M | $263.5M |
| Q1 26 | $899.4M | $520.0M | ||
| Q4 25 | $977.1M | $598.7M | ||
| Q3 25 | $899.9M | $509.8M | ||
| Q2 25 | $842.5M | $461.1M | ||
| Q1 25 | $804.1M | $467.4M | ||
| Q4 24 | $746.0M | $497.9M | ||
| Q3 24 | $683.0M | $446.3M | ||
| Q2 24 | $617.8M | $443.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.22× | ||
| Q2 24 | — | 0.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FINW
| Net Interest Income | $28.1M | 66% |
| Noninterest Income | $14.6M | 34% |
ORGO
Segment breakdown not available.
